Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota

Abstract

Obesity is associated with low-grade chronic inflammation and intestinal dysbiosis. Ganoderma lucidum is a medicinal mushroom used in traditional Chinese medicine with putative anti-diabetic effects. Here, we show that a water extract of Ganoderma lucidum mycelium (WEGL) reduces body weight, inflammation and insulin resistance in mice fed a high-fat diet (HFD). Our data indicate that WEGL not only reverses HFD-induced gut dysbiosis—as indicated by the decreased Firmicutes-to-Bacteroidetes ratios and endotoxin-bearing Proteobacteria levels—but also maintains intestinal barrier integrity and reduces metabolic endotoxemia. The anti-obesity and microbiota-modulating effects are transmissible via horizontal faeces transfer from WEGL-treated mice to HFD-fed mice. We further show that high molecular weight polysaccharides (>300 kDa) isolated from the WEGL extract produce similar anti-obesity and microbiota-modulating effects. Our results indicate that G. lucidum and its high molecular weight polysaccharides may be used as prebiotic agents to prevent gut dysbiosis and obesity-related metabolic disorders in obese individuals.

Cited by papers we hold 36

• Leaky Gut and the Ingredients That Help Treat It: A Review · 2023
  No notice
• Anti-cancer Potential of Polysaccharide Extracted From Polygonatum sibiricum on HepG2 Cells via Cell Cycle Arrest and Apoptosis · 2022
  Not checked
• Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus · 2022
  No notice
• The gut microbe Bacteroides fragilis ameliorates renal fibrosis in mice · 2022
  No notice
• Allobaculum Involves in the Modulation of Intestinal ANGPTLT4 Expression in Mice Treated by High-Fat Diet · 2021
  No notice
• Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis · 2021
  No notice
• Dietary betaine prevents obesity through gut microbiota-drived microRNA-378a family · 2021
  No notice
• Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice · 2021
  No notice
• Characteristics of gut microbiota in people with obesity · 2021
  No notice
• Advances in understanding of health‐promoting benefits of medicine and food homology using analysis of gut microbiota and metabolomics · 2020
  Not checked
• Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety · 2020
  No notice
• Role of gut microbiota in identification of novel TCM-derived active metabolites · 2020
  No notice
• Probiotic Mixture of Lactobacillus plantarum Strains Improves Lipid Metabolism and Gut Microbiota Structure in High Fat Diet-Fed Mice · 2020
  No notice
• Panax notoginseng saponins modulate the gut microbiota to promote thermogenesis and beige adipocyte reconstruction via leptin-mediated AMPKα/STAT3 signaling in diet-induced obesity · 2020
  No notice
• Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis · 2020
  No notice
• Pectin reduces environmental pollutant-induced obesity in mice through regulating gut microbiota: A case study of p,p′-DDE · 2019
  Not checked
• Organophosphorus pesticide chlorpyrifos intake promotes obesity and insulin resistance through impacting gut and gut microbiota · 2019
  No notice
• Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors · 2019
  No notice
• Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation · 2019
  No notice
• Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment · 2019
  No notice

and 16 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.